XOMA Royalty (XOMA) Retained Earnings (2010 - 2026)
XOMA Royalty's (XOMA) quarterly Retained Earnings came in at -$1.2 billion in Q1 2026, down 1031666.95% year-on-year from N/an in Q1 2025, and down 2296796.23% quarter-over-quarter from $53000.0 in Q4 2025.
XOMA Royalty (XOMA) Retained Earnings (2010 - 2026) Analysis & Trends
XOMA Royalty has disclosed Retained Earnings across 17 years of filings, most recently posting -$1.2 billion for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$1.2 billion, down 1031666.95% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 billion (down 1031666.95% YoY), and the FY2025 annual result was $53000.0, up 100.0% from the prior year.
- Retained Earnings came in at -$1.2 billion for Q1 2026 at XOMA Royalty, down from $53000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $122000.0 in Q2 2025 to a low of -$1.2 billion in Q4 2024.
- The 5-year median for Retained Earnings is -$1.2 billion (2023), against an average of -$920.6 million.
- Across the five-year window, Retained Earnings jumped 100.01% in 2025 and slumped 1031666.95% in 2026, its largest moves.
- XOMA Royalty's Retained Earnings stood at -$1.2 billion in 2022, then retreated by 3.45% to -$1.2 billion in 2023, then slipped by 1.13% to -$1.2 billion in 2024, then soared by 100.0% to $53000.0 in 2025, then plunged by 2296796.23% to -$1.2 billion in 2026.
- The last three Retained Earnings figures came in at -$1.2 billion (Q1 2026), $53000.0 (Q4 2025), and $121000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -838.07 Mn |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - | -1.22 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.22 Bn |
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | 121,000.00 |
| Jun 30, 2025 | 122,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Dec 31, 2024 | -1.24 Bn |
| Sep 30, 2024 | -1.23 Bn |
| Jun 30, 2024 | -1.22 Bn |
| Mar 31, 2024 | -1.23 Bn |
| Dec 31, 2023 | -1.22 Bn |
| Sep 30, 2023 | -1.20 Bn |
| Jun 30, 2023 | -1.20 Bn |
| Mar 31, 2023 | -1.19 Bn |
| Dec 31, 2022 | -1.18 Bn |
| Sep 30, 2022 | -1.18 Bn |
| Jun 30, 2022 | -1.17 Bn |
| Mar 31, 2022 | -1.17 Bn |
| Dec 31, 2021 | -1.17 Bn |
| Sep 30, 2021 | -1.20 Bn |
| Jun 30, 2021 | -1.19 Bn |